Article Text

Download PDFPDF

LP-084 Single cell genomics of self-reactive B cells in systemic lupus erythematosus
  1. Joanne Reed1,2
  1. 1Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, Australia
  2. 2School of Medical Sciences, University of Sydney, Australia


Background Advances in single cell genomics have illuminated aberrant cells with striking transcriptional differences in patients with systemic lupus erythematosus compared to healthy individuals. However, it is not clear whether the aberrant cells are directly responsible for pathology or bystanders that have become aberrant in response to an inflammatory environment. This is an important distinction because safer and more effective treatments rely on identifying and eliminating pathogenic cells. The goal of this study was to molecularly characterise the cells that produce pathogenic autoantibodies and determine how they differ to their normal counterparts.

Methods A multi-omics approach was employed to identify pathogenic autoreactive B-cells, which linked mass spectrometry sequencing of serum autoantibody with massively parallel sequencing of immunoglobulin expressed by circulating B-cells. Single cell sequencing was performed to compare gene expression and mutation in pathogenic and normal B-cells.

Results Rare circulating B-cells making pathogenic autoantibodies were found to comprise clonal trees accumulating mutations in immunoglobulin regions. The pathogenic cells had a distinct gene expression profile similar to that previously observed in CD21-low atypical memory B-cells.

Conclusions The detailed analysis of pathogenic B-cells reveals insights into disease pathology and therapeutic targets for precision medicine approaches.

  • autoantibodies
  • genomics
  • B cells

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.